MedTrace Logo

L-arginine Supplementation and Resistance Exercise

NCT03827005 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-02-01

No results posted yet for this study

Summary

The purpose of this study was to examine the acute endothelial, cardiovascular, and performance responses to L-arginine by assessing flow-mediated dilation (FMD) and heart rate variability (HRV) both before and after resistance exercise to fatigue. Thirty (15 male, 15 female) physically active participants volunteered for a randomized, cross-over, double-blind, placebo- controlled clinical trial. Participants completed five sets of elbow extension-flexion exercise after consumption of either 3 g of placebo or 3 g L-arginine.

Conditions

  • Healthy Adult

Interventions

DIETARY_SUPPLEMENT

L-arginine

NOW Foods, Bloomingdale, IL

DIETARY_SUPPLEMENT

Placebo

InHealth Specialty Pharmacy, Fargo, ND

Sponsors & Collaborators

  • North Dakota State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-16
Primary Completion
2017-04-30
Completion
2017-05-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03827005 on ClinicalTrials.gov